BRISTOL-MYERS SQUIBB

Lobbying client · District of Columbia · filed 2025 to 2026

Global biopharmaceutical company

$220,000 Reported spend

6 Filings counted

1 Firms hired

3 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (202100), not by name.

Firms hired 1

SPLITOAK STRATEGIES LLC $220,000 6 filings

Bills named in these filings 3

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

3 filings
HR 946
ORPHAN Cures Act

1 filing
S 1862
ORPHAN Cures Act

1 filing

Reported by year 2 years

2026 $120,000 2 filings
2025 $100,000 4 filings

Issues lobbied 1

Medicare/Medicaid 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 5
SENATE 5

Recent filings 6 total

Q2

SPLITOAK STRATEGIES LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026

View → Q1

SPLITOAK STRATEGIES LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 20, 2026

View → Q4

SPLITOAK STRATEGIES LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $50,000 income · posted Jan 20, 2026

View → Q3

SPLITOAK STRATEGIES LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $40,000 income · posted Oct 20, 2025

View → Q2

SPLITOAK STRATEGIES LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $10,000 income · posted Jul 21, 2025

View → Q1Y

SPLITOAK STRATEGIES LLC

1st Quarter (Jan 1 - Mar 31) 2025 · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.